Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 487

1.

The prognostic significance of fibrosarcomatous transformation in dermatofibrosarcoma protuberans.

Abbott JJ, Oliveira AM, Nascimento AG.

Am J Surg Pathol. 2006 Apr;30(4):436-43.

PMID:
16625088
[PubMed - indexed for MEDLINE]
2.

Fibrosarcomatous ("high-grade") dermatofibrosarcoma protuberans: clinicopathologic and immunohistochemical study of a series of 41 cases with emphasis on prognostic significance.

Mentzel T, Beham A, Katenkamp D, Dei Tos AP, Fletcher CD.

Am J Surg Pathol. 1998 May;22(5):576-87.

PMID:
9591728
[PubMed - indexed for MEDLINE]
3.

Dermatofibrosarcoma protuberans: A clinicopathologic analysis of patients treated and followed at a single institution.

Bowne WB, Antonescu CR, Leung DH, Katz SC, Hawkins WG, Woodruff JM, Brennan MF, Lewis JJ.

Cancer. 2000 Jun 15;88(12):2711-20.

PMID:
10870053
[PubMed - indexed for MEDLINE]
4.
5.

Dermatofibrosarcoma protuberans with fibrosarcomatous areas. Molecular abnormalities of the p53 pathway in fibrosarcomatous transformation of dermatofibrosarcoma protuberans.

Hisaoka M, Okamoto S, Morimitsu Y, Tsuji S, Hashimoto H.

Virchows Arch. 1998 Oct;433(4):323-9.

PMID:
9808434
[PubMed - indexed for MEDLINE]
6.

Myxoid dermatofibrosarcoma protuberans: a rare variant analyzed in a series of 23 cases.

Reimann JD, Fletcher CD.

Am J Surg Pathol. 2007 Sep;31(9):1371-7.

PMID:
17721193
[PubMed - indexed for MEDLINE]
7.

Dermatofibrosarcoma protuberans with fibrosarcomatous areas: a clinico-pathologic and immunohistochemic study in four cases.

Díaz-Cascajo C, Weyers W, Borrego L, Iñarrea JB, Borghi S.

Am J Dermatopathol. 1997 Dec;19(6):562-7.

PMID:
9415611
[PubMed - indexed for MEDLINE]
8.

CD34 positivity in fibrosarcomas which arise in dermatofibrosarcoma protuberans.

Goldblum JR.

Arch Pathol Lab Med. 1995 Mar;119(3):238-41.

PMID:
7534057
[PubMed - indexed for MEDLINE]
9.

Dermatofibrosarcoma protuberans, giant cell fibroblastoma, and hybrid lesions in children: clinicopathologic comparative analysis of 28 cases with molecular data--a study from the French Federation of Cancer Centers Sarcoma Group.

Terrier-Lacombe MJ, Guillou L, Maire G, Terrier P, Vince DR, de Saint Aubain Somerhausen N, Collin F, Pedeutour F, Coindre JM.

Am J Surg Pathol. 2003 Jan;27(1):27-39.

PMID:
12502925
[PubMed - indexed for MEDLINE]
10.

Microsatellite instability and p53 mutation associated with tumor progression in dermatofibrosarcoma protuberans.

Takahira T, Oda Y, Tamiya S, Yamamoto H, Kawaguchi K, Kobayashi C, Oda S, Iwamoto Y, Tsuneyoshi M.

Hum Pathol. 2004 Feb;35(2):240-5.

PMID:
14991543
[PubMed - indexed for MEDLINE]
11.

Dermatofibrosarcoma protuberans: an analysis of proliferative activity, DNA flow cytometry and p53 overexpression with emphasis on its progression.

Sasaki M, Ishida T, Horiuchi H, MacHinami R.

Pathol Int. 1999 Sep;49(9):799-806.

PMID:
10504551
[PubMed - indexed for MEDLINE]
12.

Giant cell fibroblastoma: an update and addition of 86 new cases from the Armed Forces Institute of Pathology, in honor of Dr. Franz M. Enzinger.

Jha P, Moosavi C, Fanburg-Smith JC.

Ann Diagn Pathol. 2007 Apr;11(2):81-8.

PMID:
17349565
[PubMed - indexed for MEDLINE]
13.

Dermatofibrosarcoma protuberans: a report on 29 patients treated by Mohs micrographic surgery with long-term follow-up and review of the literature.

Snow SN, Gordon EM, Larson PO, Bagheri MM, Bentz ML, Sable DB.

Cancer. 2004 Jul 1;101(1):28-38.

PMID:
15221986
[PubMed - indexed for MEDLINE]
Free Article
14.

Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution.

DuBay D, Cimmino V, Lowe L, Johnson TM, Sondak VK.

Cancer. 2004 Mar 1;100(5):1008-16.

PMID:
14983497
[PubMed - indexed for MEDLINE]
Free Article
15.

Transformed dermatofibrosarcoma protuberans: a clinicopathological study of eight cases.

Szollosi Z, Nemes Z.

J Clin Pathol. 2005 Jul;58(7):751-6.

PMID:
15976346
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Dermatofibrosarcoma protuberans. A clinicopathologic review with emphasis on fibrosarcomatous areas.

Connelly JH, Evans HL.

Am J Surg Pathol. 1992 Oct;16(10):921-5.

PMID:
1415902
[PubMed - indexed for MEDLINE]
17.

Dermatofibrosarcoma protuberans treated with wide local excision and followed at a cancer hospital: prognostic significance of clinicopathologic variables.

Erdem O, Wyatt AJ, Lin E, Wang X, Prieto VG.

Am J Dermatopathol. 2012 Feb;34(1):24-34. doi: 10.1097/DAD.0b013e3182120671.

PMID:
21785324
[PubMed - indexed for MEDLINE]
18.

Myxoid dermatofibrosarcoma protuberans: clinicopathologic, immunohistochemical, and molecular analysis of eight cases.

Mentzel T, Schärer L, Kazakov DV, Michal M.

Am J Dermatopathol. 2007 Oct;29(5):443-8.

PMID:
17890911
[PubMed - indexed for MEDLINE]
19.

A comparison between Mohs micrographic surgery and wide surgical excision for the treatment of dermatofibrosarcoma protuberans.

Gloster HM Jr, Harris KR, Roenigk RK.

J Am Acad Dermatol. 1996 Jul;35(1):82-7. Review.

PMID:
8682970
[PubMed - indexed for MEDLINE]
20.

[An uncommon malignancy of the breast: dermatofibrosarcoma protuberans with fibrosarcomatous transformation (DFSP-FS)].

Ledniczky G, Bognár G, Diczházi C, Bereczky B, Barabás L, Ondrejka P.

Magy Seb. 2009 Feb;62(1):27-9. doi: 10.1556/MaSeb.62.2009.1.7. Hungarian.

PMID:
19218166
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk